Introduction. Simultaneous bilateral total hip arthroplasty is now widely accepted for their economically and functionally advantages than staged total hip arthroplasty. But there is concerning higher demands of blood transfusion than unilateral procedure. Multiple studies suggest that tranexiamic acid (TXA) reduces perioperative blood loss. However there is no report for simultaneous bilateral total hip arthroplasty in these studies. Hypothesis. TXA reduces significant blood loss after bilateral total hip arthroplasty. Patients and methods. We retrospectively reviewed the records of 12 patients who did not use TXA, and 12 patients who had used TXA. There were no significant differences between the groups in terms of demographics and preoperative Hb. 1g of TXA was administered just before first skin incision and 1g was administered 6 hours after surgery. Intra operative blood loss, the amount of drainage for the first operative day and perioperative Hb changes were recorded. Results. TXA administered groups were significant lower intra operative blood loss (mean 1022 ml vs 623 mL) and drainage amount (mean 1930 mL vs 721 mL) and higher Hb levels postoperative 5 days. Conclusion. TXA significantly reduced perioperative blood loss for simultaneous bilateral total hip arthroplasty

Background. Pre-operative autologous blood donation is recommended as a means of reducing the need for allogeneic transfusion before simultaneous bilateral total hip arthroplasty (THA). However, there have been few reports on the optimal amount of autologous donation for this procedure. In this study we sought to determine the amount of autologous blood required for patient undergoing simultaneous bilateral THA using the direct anterior approach. Methods. We retrospectively enrolled 325 consecutive patients (650 hips) underwent simultaneous bilateral primary THA from January 2012 to June 2014. Thirty-three patients were men and 290 patients were women. The patients’ mean age at THA was 59.1 years. All THAs were performed using the direct anterior approach. Intraoperative blood salvage was applied for all patients and postoperative blood salvage was not applied for any patients. Results. The mean intraoperative blood loss and the mean operative time for the bilateral procedure were 413±165 g and 87.2±12.3 minutes, respectively. Two hundreds and forty-one of the 325 patients (74.2%) donated an average of 1.9 (range, 1–2) units of autologous blood before the operation. The mean hemoglobin levels on the preoperative day, postoperative day 1 and postoperative day 5 were 12.5g/dl, 10.5 g/dl and 9.5 g/dl, respectively. Only 1 patient (0.3%) required postoperative transfusions of allogeneic blood. All of the autologous units collected were transfused, and no units were wasted. Conclusion. Simultaneous bilateral THA can be performed without allogenic blood transfusion in 99.7% of patients. We could not find out significant effectiveness of an average of 1.9 units of autologous blood donation for this procedure in this study. We concluded that simultaneous bilateral THA can be performed without autologous blood donation in healthy patients without severe hip deformity. Whereas, preoperative donation of autologous blood might be suitable for patients with low body weight or patients with severe hip deformity. The minimally invasive aspect of the direct anterior approach seems to allow a low rate of allogeneic blood transfusion in the study

Simultaneous bilateral total hip arthroplasty (THA) in patients with bilateral hip osteoarthritis is gradually becoming attractive, as it requires a single anesthesia and hospitalization. However, there are concerns about the potential complications following this surgical option. The purpose of this study is to compare the short-term major and minor complications and assess the readmission rate, between patients treated with same-day bilateral THA and those with staged procedures within a year. We retrospectively reviewed the charts of all patients with bilateral hip osteoarthritis that underwent simultaneous or staged (within a year) bilateral total THA in our institution, between 2016-2020. Preoperative patient variables between the two groups were compared using the 2-sample t-test for continuous variables, the Fisher's exact test for binary variables, or the chi-square test for multiple categorical variables. Similarly, differences in the 30-day major and minor complications and readmission rates were assessed. A logistic regression model was also developed to identify potential risk factors. A total of 160 patients (mean age: 64.3 years, SD: ±11.7) that underwent bilateral THA was identified. Seventy-nine patients were treated with simultaneous and eighty-one patients with staged procedures. There were no differences in terms of preoperative laboratory values, gender, age, Body Mass Index (BMI), or American Society of Anesthesiologists Scores (ASA) (p>0.05) between the two groups. Patients in the simultaneous group were more likely to receive general anesthesia (43% vs 9.9%, p0.05). After controlling for potential confounders, the multivariable logistic regression analysis showed similar odds of having a major (odds ratio 0.29, 95% confidence interval [0.30-2.88], p=0.29) or minor (odds ratio 1.714, 95% confidence interval [0.66-4.46], p=0.27) complication after simultaneous compared to staged bilateral THA. No differences in emergency department visits or readmission for reasons related to the procedure were recorded (p>0.05). This study shows that similar complication and readmission rates are expected after simultaneous and staged THAs. Simultaneous bilateral THA is a safe and effective procedure, that should be sought actively and counselled by surgeons, for patients that present with radiologic and clinical bilateral hip disease

Simultaneous bilateral total hip arthroplasties (THAs) present unique and unwarranted dangers to the patient and surgeon alike. These include a significantly increased risk of blood transfusion (up to 50% in contemporary series even with the use of tranexamic acid), longer operative times, longer length of stays, and higher mortality rates in patients with minimal risk factors (age > 75 years, rheumatoid arthritis, higher ASA class, and/or male sex). This is even in light of the fact that the vast majority of literature has a substantial selection bias in which only the healthiest, youngest, non-obese, and most motivated patients are included. Traditionally, simultaneous bilateral THAs were completed in the lateral decubitus position. This required the surgeon and surgical team to reposition the patient onto a fresh wound, as well as additional prepping and draping. To mitigate these additional limitations of simultaneous bilateral THAs, there has been a recent trend towards utilizing the direct anterior approach. However, this particular approach presents its own unique set of complications such as an increased risk of periprosthetic femoral fracture and early femoral failure, an increased risk of impaired wound healing (particularly in obese patients), potential injury to the lateral femoral cutaneous nerve with subsequent neurogenic pain, and traction-related neurologic injuries. When compounded with the risks of simultaneous bilateral THAs, the complication profile becomes prohibitive for an elective procedure with an otherwise very low morbidity

Introduction: A potential cause of premature loosening of the total hip prosthesis in patients with osteonecrosis is abnormal cancellous bone in the acetabulum and proximal femur. The purpose of this prospective study was to investigate the hypothesis that osteonecrosis is not confined to the femoral head but may extend proximally into acetabulum and distally into the proximal femoral bone. Also, the clinical and radiographic results of total hip arthroplasty with so-called third-generation cementless total hip prostheses were evaluated in sixty-three consecutive patients with osteonecrosis of the femoral head. Materials and Methods: Twenty-five patients who had simultaneous bilateral total hip arthroplasty, and thirty-eight patients who had a unilateral total hip arthroplasty were included in the study. A cementless acetabular and femoral component were used in all hips. There were fifty-five men and eight women. The mean age at the time of the arthroplasty was 47 years (range, twenty-five to sixty-four years). We performed histological examination of the femoral heads and cancellous bone biopsies from five regions of the hip in patients undergoing total hip arthroplasty. Clinical and radiographic evaluations were performed preoperatively; at six weeks; at three, six, and twelve months; and yearly thereafter. The average duration of follow-up was 4.9 years. Results: The majority of patients with idiopathic or alcohol induced osteonecrosis had normal bone in the acetabulum and proximal femur. The average Harris hip scores in the group treated with unilateral arthroplasty (96 points) and the group treated with bilateral arthroplasty (94 points) were similar at the time of final follow-up. No component had aseptic loosening. In one hip (1%), an acetabular component and a femoral component were revised because of infection. No hip had detectable wear or osteolysis in the acetabulum or in the proximal femur. Conclusions: Normal or nearly normal cancellous bone in the acetabulum and proximal femur and advancements in surgical technique and better designs have greatly improved the intermediate-term survival of cementless total hip implants in young patients with osteonecrosis of the femoral head. An absence of osteolysis in these high-risk young patients is partly related to use of ceramic-on-ceramic bearing; solid fixation of the component; and short-term follow-up

Introduction: The rate of failure of primary total hip arthroplasty in patients with osteonecrosis of the femoral head is higher than in patients with osteoarthritis. The purpose of this prospective study was to document the clinical and radiographic results of arthroplasty with so-called third generation cementing and the results of second generation cementless total hip arthroplasty in ninety-eight consecutive patients with osteonecrosis of the femoral head. Materials and Methods: Fifty patients who had simultaneous bilateral total hip arthroplasties with a cemented stem in one hip and a cementless stem in the other and forty-eight patients who had unilateral total hip arthroplasties with a cementless stem were included in the study. A cementless acetabular component was used in all hips. The presumed cause of the osteonecrosis was ethanol abuse in fifty-seven patients, unknown in twenty-seven, fracture of the femoral neck in nine, and steroid use in five. There were eighty men and eighteen women. The mean age the time of the arthroplasty was 47 years (range, twenty-six to fifty-eight years). Clinical and radiographic evaluations were performed preoperatively, at six weeks, at three, six, and twelve months; yearly thereafter. The average duration of follow-up was 9.3 years. Results: The average Harris hip scores in the group treated with unilateral arthroplasty (97 points) and the group treated with bilateral arthroplasty (94 points) were similar at the time of final follow-up. They were also similar between the group treated with cement (mean, 96 points) and that treated without cement (95 points). No component had aseptic loosening in either group. In one hip, a cemented femoral stem (2 %) and a cementless cup were revised because of infection. Two cementless stems (2%) were revised because of fracture of the proximal part of the femur with loosening of the stem. Annual wear of the polyethylene liner averaged 0.22 mm in the group treated with cement (a zirconia head) and 0.14 mm in the group treated without cement (a cobalt-chrome head). The prevalence of osteolysis in zones 1 and 7 of femur was 16 % in the femur was 16% in the group treated with cement and 24% in the group treated without cement. Discussion: Advances in surgical technique and better designs have greatly improved the long-term survival of cemented and cementless implants in young patients with osteonecrosis of femoral head. Although there was no aseptic loosening of the components, the high rate of linear wear of the polyethylene liner and high rate of osteolysis in these high risk young patients remain challenging problems